Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Conditions

• Female, Age ≥ 18 Years Old
• No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy
• ECOG Score of 0-1
• Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion
• Sufficient Organ Function
• The Result of the Urine or Serum Pregnancy Test for the Subject is Negative
• Subjects Should Take Contraceptive Measures
• Locally Advanced Cervical Cancer
• Expected Survival Time >6 Months

Interventions

• DRUG: Cadonilimab combined with cisplatin

Sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborators

• [object Object]
• [object Object]